What the analyst said
UBS analyst Karl Keirstead raised the price target on Palantir (NASDAQ: PLTR) to $200.00 (from $180.00) while maintaining a Buy rating.
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.
This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.
Where the price stands
PLTR trades at $143. The 19 analysts who set a target in the last 3 months range from $130 to $273, with a median of $250. This $200 target is 20% below the median.
Since the note PLTR has moved −7% (from $155). 12-month window: day 249 of 365, closes on March 18, 2027.
Track record
This call✓ Target reached on October 9, 2026, 7 months after the note.
Firm track recordUBS: 83% of its 59 targets at least a year old were reached within 12 months (#6 of 29 firms); on Palantir, 4 of 5. Accuracy ranking →
UBS on Palantir
UBS price targets on Palantir
8 calls from August 5, 2025 to August 4, 2026. The target went from $165 to $220 (+33%). The rating moved from Hold to Buy.
- August 4, 2026Target raised from $200 (+10%)Buy$220
- June 16, 2026Kept the $200 targetBuy$200
- March 18, 2026 This noteTarget raised from $180 (+11%)Buy$200
- February 26, 2026Upgraded to Buy, kept the $180 targetBuy$180
- February 3, 2026Target cut from $205 (−12%)Hold$180
- November 4, 2025Target raised from $165 (+24%)Hold$205
- September 9, 2025Kept the $165 targetHold$165
- August 5, 2025Earliest call shownHold$165





